Editorial Policies

This website is intended to provide the Group's stakeholders, including patients, healthcare professionals, local communities, and employees, with information about major sustainability initiatives implemented by the Group in fiscal 2022. Specific initiatives implemented in accordance with the Company's philosophy are presented in line with management, the environment, and society. Additionally, it also features descriptions of the Mitsubishi Chemical Group (the MCG Group) initiatives and activities undertaken under the “One Company, One Team” system.

The Sustainability Report 2023 PDF version, which contains the same content as disclosed on this website, can be downloaded from the Sustainability Report archive page.

Explanations of medical and pharmaceutical terms appearing in this report have been provided to foster a wider understanding of the report's content.

Applied Guidelines
  • Global Reporting Initiative (GRI) Sustainability Reporting Standard;
  • Environmental Reporting Guidelines, 2018 version, published by the Ministry of the Environment of Japan
Period covered April 1, 2022, to March 31, 2023
(The report includes examples of activities from April 2022 and thereafter)
Issue timing September 2023
(Previous report: September 2022; next report: September 2024)
Scope of reporting Mitsubishi Tanabe Pharma and consolidated subsidiaries in Japan and overseas.
(The scope of reporting could differ in accordance with the examples being reported.)
Contact information

Contact Us

This website uses cookies to provide better content. By browsing this site, you accept our use of cookies.
Privacy Policy